Savara Pharmaceuticals
SVRA
#6616
Rank
โ‚น46.91 B
Marketcap
โ‚น273.35
Share price
-1.23%
Change (1 day)
-28.44%
Change (1 year)

Revenue for Savara Pharmaceuticals (SVRA)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Savara Pharmaceuticals from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚น18.79 M
2019 N/A
2018 N/A
2017 N/A-100%
2016 โ‚น5.64 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A-100%
2010 โ‚น21.91 M-47.53%
2009 โ‚น41.76 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น19.18 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น60.39 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA